Wealthfront Advisers LLC Buys 17,154 Shares of Cigna Group $CI

Wealthfront Advisers LLC raised its stake in shares of Cigna Group (NYSE:CIFree Report) by 56.2% in the 4th quarter, Holdings Channel reports. The firm owned 47,661 shares of the health services provider’s stock after acquiring an additional 17,154 shares during the period. Wealthfront Advisers LLC’s holdings in Cigna Group were worth $13,118,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. HM Payson & Co. raised its holdings in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after acquiring an additional 35 shares in the last quarter. OLD National Bancorp IN lifted its position in Cigna Group by 3.7% during the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after purchasing an additional 37 shares during the last quarter. Leavell Investment Management Inc. boosted its holdings in shares of Cigna Group by 3.8% in the 3rd quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider’s stock worth $318,000 after purchasing an additional 40 shares during the period. Physician Wealth Advisors Inc. lifted its stake in Cigna Group by 1.5% in the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after purchasing an additional 41 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. grew its stake in Cigna Group by 0.8% in the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after acquiring an additional 41 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Shares of CI opened at $284.66 on Wednesday. The firm has a market capitalization of $75.02 billion, a PE ratio of 12.83, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company’s fifty day moving average price is $274.20 and its 200-day moving average price is $276.74.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the prior year, the firm earned $6.64 earnings per share. Cigna Group’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts predict that Cigna Group will post 30.32 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CI. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Piper Sandler lowered their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Mizuho set a $325.00 price objective on shares of Cigna Group in a report on Friday, January 9th. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, TD Cowen increased their target price on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $332.47.

View Our Latest Analysis on CI

Insider Transactions at Cigna Group

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.